Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Caveolin-1–dependent apoptosis induced by fibrin degradation products

Yi-He Guo, Irene Hernandez, Berend Isermann, Tae-bong Kang, Leonid Medved, Rashmi Sood, Edward J. Kerschen, Trudy Holyst, Michael W. Mosesson, Hartmut Weiler

Blood (2009) 113 (18): 4431–4439.

https://doi.org/10.1182/blood-2008-07-169433

Published: 2009

Journal Articles

Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains

Kevin R. Siebenlist, Michael W. Mosesson, Irene Hernandez, Leslie A. Bush, Enrico Di Cera, John R. Shainoff, James P. Di Orio, Laurie Stojanovic

Blood (2005) 106 (8): 2730–2736.

https://doi.org/10.1182/blood-2005-01-0240

Published: 2005

Journal Articles

Fibrinogen contributions to arterial thrombus formation: vessel size counts

Michael W. Mosesson

Blood (2004) 103 (6): 1977–1978.

https://doi.org/10.1182/blood-2004-01-0038

Published: 2004

Journal Articles

Cause-effect relation between hyperfibrinogenemia and vascular disease

Bryce Kerlin, Brian C. Cooley, Berend H. Isermann, Irene Hernandez, Rashmi Sood, Mark Zogg, Sara B. Hendrickson, Michael W. Mosesson, Susan Lord, Hartmut Weiler

Blood (2004) 103 (5): 1728–1734.

https://doi.org/10.1182/blood-2003-08-2886

Published: 2004

Journal Articles

Afibrinogenemia in a compound heterozygote: making sense out of missense

Michael W. Mosesson

Blood (2003) 102 (13): 4247–4248.

https://doi.org/10.1182/blood-2003-09-3255

Published: 2003

Journal Articles

Introduction: fibrinogen as a determinant of the metastatic potential of tumor cells

Michael W. Mosesson

Blood (2000) 96 (10): 3301.

https://doi.org/10.1182/blood.V96.10.3301

Published: 2000

Journal Articles

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158

Teruko Sugo, Chizuko Nakamikawa, Hiroshi Takano, Jun Mimuro, Shu-ichi Yamaguchi, Michael W. Mosesson, David A. Meh, James P. DiOrio, Noriko Takahashi, Hoyu Takahashi, Koichi Nagai, Michio Matsuda

Blood (1999) 94 (11): 3806–3813.

https://doi.org/10.1182/blood.V94.11.3806

Published: 1999

NARROW

Caveolin-1–dependent apoptosis induced by fibrin degradation products

Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains

Fibrinogen contributions to arterial thrombus formation: vessel size counts

Cause-effect relation between hyperfibrinogenemia and vascular disease

Afibrinogenemia in a compound heterozygote: making sense out of missense

Introduction: fibrinogen as a determinant of the metastatic potential of tumor cells

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158

Email alerts

ASH Publications

American Society of Hematology

Caveolin-1–dependent apoptosis induced by fibrin degradation products

Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains

Fibrinogen contributions to arterial thrombus formation: vessel size counts

Cause-effect relation between hyperfibrinogenemia and vascular disease

Afibrinogenemia in a compound heterozygote: making sense out of missense

Introduction: fibrinogen as a determinant of the metastatic potential of tumor cells

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only